Skip to main content
Glenmark Pharmaceuticals Ltd (GLENMARK)

Glenmark Pharmaceuticals Ltd share price, charts, financials, and analysis on WealthOrbit.

Glenmark Pharmaceuticals Ltd

Healthcarelarge_cap

GLENMARK · NSE · Drug Manufacturers - Specialty & Generic

2,305
-1.03%-24

Live · Prev close ₹2,329

Market Cap

₹65.7 K

P/E

36.53x

P/B

6.25x

ROE

14.07%

ROCE

25.1%

D/E

0.06

Div Yield

0.32%

Book Val

₹372.48

Price Ranges

Day Low: ₹2,305Day High: ₹2,332.9
52W Low: ₹1,792.652W High: ₹2,474

Price Chart

No chart data available

Returns

Analysis· Based on latest data

Pros

  • Good ROCE of 25.1%
  • Low debt-to-equity ratio of 0.06 — conservatively funded
  • Healthy operating margin of 15.7%

Cons

  • High P/B ratio of 6.3x — above book value premium

* Auto-generated from financial ratios. Do your own analysis before investing.

Company Info

ISIN

INE935A01035

Series

A

Industry

Drug Manufacturers - Specialty & Generic

Listed

10 Feb 2000

HQ

Mumbai, India

Face Val

₹1

Glenmark Pharma Ltd is a leading company in the Pharmaceuticals space, listed on NSE and BSE.

Fundamentals

TTM P/E36.53x
P/B Ratio6.25x
EPS (TTM)₹63.76
ROE14.07%
ROCE25.1%
Debt / Equity0.06
Revenue (TTM)₹17.7 K
Net Profit (TTM)₹1.8 K
Promoter Holding48.96%

Peer Comparison

Loading related news…